, Flow Cytometry Resource Facility (FCRF) The Flow Cytometry Resource Facility (FCRF) of the Indiana University Simon Cancer Center (IUSCC) supports the research efforts of members of the Cancer Center. Flow cytometric services are integral and critical services for the research activities of a large number of IUSCC members in all programs of the Center. Access to a comprehensive array of flow cytometric applications such as cell sorting both in bulk and as single cells, immunophenotypic analysis, cell cycle analysis, and genomic and metabolic regulation at the single cell level, is an invaluable resource for cancer research. A centralized core offering an array of flow cytometric technologies provides several advantages over the acquisition of these tools on an individual basis. Furthermore, the FCRF offers state-of-the-art services at a much-reduced cost to IUSCC members making it simpler and more efficient to provide these services through a shared facility. The infrastructure and organizational arrangements of the FCRF are well established as this facility has been on the campus of the IU School of Medicine for more than three decades and has been led by the core director the since 1989. Eight of the 11 instruments currently housed in the FCRF, including a recently acquired CyTOF2, were added since early 2014. The FCRF core proposes two specific aims: 1) to provide outstanding, consistent, timely, and economical multicolor analysis, cell sorting, image flow analysis, and single cell genomics and proteomic analysis to all IUSCC members to facilitate their cancer-focused research; and 2) to provide expertise to enhance the productivity of IUSCC members by providing advice and consultations on how investigations can best make use of the centralized and standardized cost-effective flow cytometric and other related services. This includes the exchange of protocols and results between investigators and advancing the distribution of scientific knowledge. Through institutional and IUSCC support, the FCRF continues to provide cutting-edge capabilities to promote pioneering research by IUSCC members and allow them to apply advanced technologies to their research. As a shared core facility with advanced technologies, the FCRF is an economic and essential resource to many IUSCC members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA082709-21
Application #
9987548
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1999-09-22
Project End
2024-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Huang, Xinxin; Guo, Bin; Liu, Sheng et al. (2018) Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment. Nat Commun 9:2741
Serratore, Nina D; Baker, Kortany M; Macadlo, Lauren A et al. (2018) A Novel Sterol-Signaling Pathway Governs Azole Antifungal Drug Resistance and Hypoxic Gene Repression in Saccharomyces cerevisiae. Genetics 208:1037-1055
Hoggatt, Jonathan; Singh, Pratibha; Tate, Tiffany A et al. (2018) Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell 172:191-204.e10
Filley, Anna; Henriquez, Mario; Bhowmik, Tanmoy et al. (2018) Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas. J Neurooncol 137:469-479
Sishtla, Kamakshi; Pitt, Natalie; Shadmand, Mehdi et al. (2018) Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14. Sci Rep 8:16152
Koh, Byunghee; Abdul Qayum, Amina; Srivastava, Rajneesh et al. (2018) A conserved enhancer regulates Il9 expression in multiple lineages. Nat Commun 9:4803
Reese, Michael J; Knapp, Deborah W; Anderson, Kimberly M et al. (2018) In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs. PLoS One 13:e0203517
Singh, Pratibha; Fukuda, Seiji; Liu, Liqiong et al. (2018) Survivin Is Required for Mouse and Human Bone Marrow Mesenchymal Stromal Cell Function. Stem Cells 36:123-129
Olivos 3rd, David J; Perrien, Daniel S; Hooker, Adam et al. (2018) The proto-oncogene function of Mdm2 in bone. J Cell Biochem 119:8830-8840
Shiue, Kevin; Cerra-Franco, Alberto; Shapiro, Ronald et al. (2018) Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy. J Thorac Oncol 13:1549-1559

Showing the most recent 10 out of 256 publications